Меню
Идёт набор NCT07087093

Effects of Ketone Esters on Circulating Senescent T Lymphocytes (T Cells) and Inflammation Levels in the Elderly

Без фазы С лечением The Elderly

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Ketone ester.
Кому может быть актуально
Состояния в реестре: The Elderly. Базовые параметры: 65 лет — 80 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

Studies have shown that aging can promote a variety of pathological processes, such as myocardial remodeling and cardiac dysfunction caused by ischemia-reperfusion injury and pressure load. Previous studies found that the level of circulating beta-hydroxybutyric acid decreased significantly with age. It has been reported that the ketogenic diet reduces the occurrence of tumors and neurodegenerative diseases in mice, improves motor coordination and endurance, and ultimately extends life span. Current research results have confirmed that ketone bodies have multiple mechanisms to exert beneficial effects on cardiovascular diseases. However, the effect of age-related cardiovascular disease has not been reported. In order to further clarify the role of beta-hydroxybutyric acid in age-related cardiovascular diseases, find new intervention targets for elderly cardiovascular diseases, and develop new effective prevention and treatment measures for elderly cardiovascular diseases. We will further investigate this hypothesis by establishing a clinical cohort of the elderly population.

Подробное описание

It is predicted that by 2050, the total number of people over 65 years old in China will reach 400 million (accounting for 26.9% of the total population), and the number of people over 80 years old will reach 150 million. Population aging is the main driving force of cardiovascular diseases, and cardiovascular diseases in the elderly will become a major clinical problem threatening the health of our people and a social problem involving people's livelihood. Therefore, it is an important research direction in the cardiovascular field to deeply explore the pathogenesis of elderly cardiovascular diseases and find effective prevention and control targets.

Studies have shown that aging can promote a variety of pathological processes, such as myocardial remodeling and cardiac dysfunction caused by ischemia-reperfusion injury and pressure load. Previous studies found that the level of circulating beta-hydroxybutyric acid decreased significantly with age. It has been reported that the ketogenic diet reduces the occurrence of tumors and neurodegenerative diseases in mice, improves motor coordination and endurance, and ultimately extends life span. Current research results have confirmed that ketone bodies have multiple mechanisms to exert beneficial effects on cardiovascular diseases. However, the effect of age-related cardiovascular disease has not been reported.

In order to further clarify the role of beta-hydroxybutyric acid in age-related cardiovascular diseases, find new intervention targets for elderly cardiovascular diseases, and develop new effective prevention and treatment measures for elderly cardiovascular diseases. We will further investigate this hypothesis by establishing a clinical cohort of the elderly population.

Вмешательства

  • Другое Ketone ester
    KetoneAid Ke4 Pro Ketone Ester:20ml, tid po

Первичные конечные точки

  • T cell senescence level (Protein 53、Protein 21 and Protein 16) [Срок оценки: From enrollment to the end of treatment at 2 weeks]
Вторичные конечные точки (2)
  • Circulating inflammatory factor levels (monocyte chemoattractant protein-1 and interleukin-6) [Срок оценки: From enrollment to the end of treatment at 2 weeks]
  • Ankle-brachial index [Срок оценки: From enrollment to the end of treatment at 2 weeks]

Критерии участия

Критерии включения

  • Age: 65\~80 years old.
  • The subjects are in good health, and no history of chronic diseases.

Критерии исключения

  • Have used immunosuppressants or hormone drugs in the past six months.
  • There has been a significant change in diet within the past month.
  • Having digestive tract surgery within one year.
  • Severe liver dysfunction (alanine aminotransferase level > 3.0 upper limit of normal).
  • Severe kidney dysfunction (creatinine clearance rate < 30 mL/min).
  • History of malignant tumor.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Китай · 1 центр
  • the First Affiliated Hospital, Harbin Medical University — Харбин

Идентификаторы

NCT: NCT07087093 · Ketone Esters-2024214

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗